Novanta Inc. (NASDAQ:NOVT – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday after Robert W. Baird lowered their price target on the stock from $169.00 to $160.00. Robert W. Baird currently has a neutral rating on the stock. Novanta traded as low as $136.02 and last traded at $139.83, with a volume of 300155 shares. The stock had previously closed at $143.37.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of NOVT. Norges Bank acquired a new position in shares of Novanta during the fourth quarter worth approximately $48,442,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of Novanta by 69.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 680,169 shares of the technology company’s stock valued at $103,910,000 after purchasing an additional 279,793 shares during the period. WCM Investment Management LLC acquired a new stake in shares of Novanta in the 4th quarter worth approximately $15,104,000. Schroder Investment Management Group raised its stake in shares of Novanta by 52.5% in the 4th quarter. Schroder Investment Management Group now owns 271,583 shares of the technology company’s stock worth $41,359,000 after buying an additional 93,511 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Novanta by 2,714.7% in the 4th quarter. Millennium Management LLC now owns 88,297 shares of the technology company’s stock valued at $13,489,000 after acquiring an additional 85,160 shares during the last quarter. Institutional investors own 98.35% of the company’s stock.
Novanta Price Performance
The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The company has a market cap of $5.13 billion, a price-to-earnings ratio of 85.43 and a beta of 1.34. The company’s 50 day moving average price is $147.87 and its 200-day moving average price is $163.53.
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- Investing In Preferred Stock vs. Common Stock
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Insider Selling Explained: Can it Inform Your Investing Choices?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- The How And Why of Investing in Oil Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.